Hypoimmune induced pluripotent stem cell–derived cell therapeutics treat cardiovascular and pulmonary diseases in immunocompetent allogeneic mice

T. Deuse(University of California, San Francisco), Sonja Schrepfer(University of California, San Francisco)

Proceedings of the National Academy of Sciences

July 9, 2021

10.1073/pnas.2022091118

Cited by 53

Related Papers

Hypoimmune induced pluripotent stem cells survive long term in fully immunocompetent, allogeneic rhesus macaques

|Nature Biotechnology|2023|145

Hypoimmune anti-CD19 chimeric antigen receptor T cells provide lasting tumor control in fully immunocompetent allogeneic humanized mice

|Nature Communications|2023|81

Hypoimmune FK binding protein 12-knockout CD19 CAR T cells achieve deep tissue B-cell depletion and control Nalm6 tumors in immunosuppressed humanized mice

|Cytotherapy|2025|1